Story
UK Unsecured Lending Hits Record Pace as Mortgage Approvals Fall

Summary
British households increased their unsecured borrowing at the fastest annual rate on record in August, according to Bank of England data, while mortgage approvals for home purchases fell to an eight-month low.
British households increased their unsecured borrowing at the fastest annual pace on record in August, even as the housing market cooled with mortgage approvals falling to their lowest level since December 2023. The figures, released by the Bank of England, paint a mixed picture of consumer financial health amid a shifting economic landscape.
Consumer Borrowing Accelerates
Unsecured lending to households, which includes credit cards and personal loans, surged by £2.464 billion ($3.26 billion) in August. This marks the most rapid annual growth rate since the data series began in 1993, according to the central bank. The Bank of England noted that the figures are not adjusted for inflation.
The increase significantly outpaced the £1.9 billion rise that economists had forecast. The data suggests consumers may be increasingly turning to credit to manage their finances.
Housing Market Shows Signs of Cooling
In contrast to the surge in consumer credit, activity in the property market showed signs of slowing. The number of mortgage approvals for house purchases fell to 54,918 in August, down from 55,928 in July.
AdThis figure is the lowest level of mortgage approvals recorded since December 2023 and fell short of the median forecast of 56,100 from economists. The decline points to weakening demand in the UK housing sector, a potential consequence of higher borrowing costs or economic uncertainty.
Economic Implications
The divergent data presents a complex picture for the UK economy. The sharp, unadjusted rise in unsecured lending could indicate that consumers are using debt to maintain spending levels, potentially in the face of cost-of-living pressures.
Simultaneously, the slowdown in the housing market suggests that higher interest rates are dampening demand for major purchases. These contrasting trends will be closely monitored by policymakers for insights into both consumer resilience and potential financial stress.
Read next
More on Stocks
Summit Therapeutics Stock Soars on $2 Billion AstraZeneca Investment, Cancer Drug Collaboration
Summit Therapeutics shares surged over 20% after AstraZeneca announced a $2 billion strategic investment and a clinical collaboration to test combination cancer therapies, signaling strong confidence in Summit's lead drug candidate.

Hapag-Lloyd Stock Rallies After Second 2026 Profit Guidance Upgrade
Shares in the German shipping giant surged after it significantly raised its full-year earnings forecast for the second time, citing strong demand and favorable spot freight rates.

Smiths News Lifts FY2026 Forecast on Strong Collectables and World Cup Sales
The UK news wholesaler announced it expects full-year results to beat market expectations, driven by a record contribution from the FIFA World Cup and robust demand for collectables, sending its shares higher.

Vinci Shares Tumble to 52-Week Low on French Infrastructure Tax Proposal
Shares in French infrastructure giant Vinci fell sharply after the government proposed a new tax on transport concession operators, prompting analysts to warn of a significant hit to earnings.